You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 818 Combination therapy with anti-PD1 and anti-LAG3 leads to unique peripheral and intratumoral CD8+ T cells signatures in patients with metastatic melanoma

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
818 Combination therapy with anti-PD1 and anti-LAG3 leads to unique peripheral and intratumoral CD8+ T cells signatures in patients with metastatic melanoma
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to August 2024

AbstractFullPdf
Nov 2022179019
Dec 20224805
Jan 20234002
Feb 20234204
Mar 20232601
Apr 202364012
May 20233801
Jun 20235604
Jul 202370010
Aug 20231704
Sep 20232804
Oct 20234404
Nov 20232402
Dec 20235406
Jan 20241401
Feb 20241401
Mar 202426038
Apr 202474015
May 20244203
Jun 20242603
Jul 20243501
Aug 20242206
Total9830146